Cargando…
Chondroblastoma: Is intralesional curettage with the use of adjuvants a sufficient way of therapy?
BACKGROUND: Chondroblastoma is a rare benign cartilaginous bone tumor that represents 1–2% of all primary bone tumors. It is characterized by aggressive growth, possible recurrence after surgical treatment and, in rare cases, metastasis. Surgical management is the primary treatment and includes intr...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750402/ https://www.ncbi.nlm.nih.gov/pubmed/33364155 http://dx.doi.org/10.1016/j.jbo.2020.100342 |